NCT00298870View on ClinicalTrials.gov

Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)

PHASE4CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

June 30, 2005

Conditions
Pulmonary Tuberculosis
Interventions
DRUG

Isoniazid

Modified daily isoniazid dose : approx. 7.5 mg/kg, 5 mg/kg and 2.5 mg/kg for rapid, intermediate and slow acetylators, respectively

DRUG

isoniazed

Conventional standard daily isoniazid dose : approx. 5 mg/kg b.w. for all

Trial Locations (4)

583-8588

Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino

572-0801

Osaka Hospital, Anti-Tuberculosis Association, Osaka Branch, Neyagawa

591-8555

National Hospital Organization Kinki-chuo Chest Medical Center, Sakai

560-8552

National Hospital Organization Toneyama, Toyonaka

All Listed Sponsors
lead

Osaka University

OTHER

NCT00298870 - Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) | Biotech Hunter | Biotech Hunter